Park Medi World CEO, chairman, board of directors and AGM
NSE: PARKHOSPSBSE: 544645Healthcare ServicesSmall Cap
Share price at the NSE close on 28 Oct 2026. Previous close ₹229.70.
28 Oct: open ₹231.70, high ₹231.95, low ₹226.00
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹9,803 Cr578th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- No full year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 4.85
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonesince listing in Dec 2025
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.11
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 2,94,73843.5% delivered
Park Medi World's chairperson is Ajit Gupta, its managing director Ankit Gupta and its chief executive Sanjay Sharma, as filed for the quarter to Sep 2026. Its latest annual general meeting was on 22 Sep 2026.
Park Medi World board of directors
At the end of the quarter to Sep 2026, as the company filed it; changes since are in its announcements.Their trades in its shares
- ChairpersonAjit GuptaRelated to the promoter
- Managing directorAnkit Gupta
- Chief executiveSanjay Sharma
- Company Secretary and Compliance OfficerAbhishek Kapoor
6 directors3 independent3 executive
- Ajit Gupta · ChairpersonExecutive · joined Jan 2011 · 1 listed board · 2 committee seats
- Ankit Gupta · Managing directorExecutive · joined Jul 2024 · 1 listed board
- Sanjay Sharma · Chief executiveExecutive · joined Aug 2021 · 1 listed board · 1 committee seat
- Ravi Krishan TakkarIndependent · joined May 2024 · reappointed May 2024 · 28 months as independent · 2 listed boards · 2 as independent · 1 committee seat, 1 as chair
- Munish SibalIndependent · joined May 2024 · reappointed May 2024 · 28 months as independent · 1 listed board · 1 as independent · 1 committee seat, 1 as chair
- Kamlesh KohliIndependent · joined May 2024 · reappointed May 2024 · 28 months as independent · 1 listed board · 1 as independent · 1 committee seat
An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.
Committees and meetings
Who sits on each, and how often they met.Board meeting notices and outcomes
Board
- 31 Aug 20266 of 6 present3 independent · 27 days in between
- 3 Aug 20266 of 6 present3 independent · 69 days in between
- 25 May 20266 of 6 present3 independent · 9 days in between
- 15 May 20266 of 6 present3 independent · 2 days in between
1 earlier meeting
- 12 May 20266 of 6 present3 independent
Audit Committee
Chair Ravi Krishan Takkar
Kamlesh Kohli, Ajit Gupta
- 3 Aug 20263 of 3 present2 independent · 79 days in between
- 15 May 20263 of 3 present2 independent · 2 days in between
- 12 May 20263 of 3 present2 independent
Nomination and remuneration committee
Chair Munish Sibal
Kamlesh Kohli, Ravi Krishan Takkar
- 15 May 20263 of 3 present3 independent
Stakeholders Relationship Committee
Chair Munish Sibal
Ajit Gupta, Sanjay Sharma
No meeting listed in the filing.
Risk Management Committee
Chair Sanjay Sharma
Munish Sibal, Rajesh Sharma
- 15 Jul 20262 of 2 present1 independent · 90 days in between
- 15 Apr 20262 of 2 present1 independent
Corporate Social Responsibility Committee
Chair Ajit Gupta
Ankit Gupta, Munish Sibal
- 15 May 20263 of 3 present1 independent
Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.
Statutory auditor
Named in the results for the quarter to Jun 2026.
- Agiwal and associatesPeer-review certificate valid to Feb 2029
A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.
Park Medi World AGM and shareholder votes
Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.
Annual general meeting, 22 Sep 2026
55,067 shareholders on the register on 15 Sep 2026; present: 1 promoter and 75 others; votes counted by Deepak Sharma / Sharma Jain & Associates.
To receive, consider and adopt the audited standalone and consolidated Financial Statements of the Company for the financial year ended March 31, 2026 along-with the reports of the Board of Directors and the Auditors thereon.MoreLess
Ordinary100.00% for0.00% againstAgainst: promoters 0.00% · institutions 0.00% · other public 0.61%
Turnout: all 89.96% · promoters 100.00% · institutions 59.52% · other public 0.11%
- To appoint Dr. Sanjay Sharma who retires by rotation as a Director and being eligible, offers himself for re-appointment.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 2.50%
Turnout: all 89.96% · promoters 100.00% · institutions 59.52% · other public 0.11%
- To ratify remuneration payable to M/s. Sachin Gupta & Co., Cost Accountants, Cost Auditor for the financial year 2026-27.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 2.12%
Turnout: all 89.96% · promoters 100.00% · institutions 59.52% · other public 0.11%
- To appoint SBR & Co. LLP, Practicing Company Secretaries, as Secretarial Auditors of the Company from the financial year 2025-26 to 2029-30.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 1.41%
Turnout: all 89.96% · promoters 100.00% · institutions 59.52% · other public 0.11%
- To amend and ratify the PARK – Employee Stock Option Scheme 2025 as per SEBI (Share Based Employee Benefit and Sweat Equity) Regulations, 2021.Special99.04% for0.96% against
Against: promoters 0.00% · institutions 12.27% · other public 7.42%
Turnout: all 89.96% · promoters 100.00% · institutions 59.52% · other public 0.11%
- To amend and ratify extension of “PARK – Employee Stock Option Scheme 2025” to the Employees of Subsidiary Companies and Group Companies of the Company.Special93.72% for6.28% against
Against: promoters 0.00% · institutions 80.03% · other public 7.76%
Turnout: all 89.96% · promoters 100.00% · institutions 59.52% · other public 0.11%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Postal ballot, 3 Sep 2026, 1 resolution
53,717 shareholders on the register on 31 Jul 2026; votes counted by Deepak Sharma / Sharma Jain and Associates.
- Amending certain objects of Initial Public Offer (“IPO”) proceedsSpecial100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 8.09%
Turnout: all 91.48% · promoters 100.00% · institutions 71.23% · other public 0.22%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
How mutual funds voted
Fund houses must disclose how they vote at every meeting of a company they hold.Funds that hold it
Mutual fund votes, meeting of 22 Sep 2026, 9 fund houses
Each resolution counts the houses whose vote was matched to it; the rest are listed last.
To receive, consider and adopt the audited standalone and consolidated Financial Statements of the Company for the financial year ended March 31, 2026 along-with the reports of the Board of Directors and the Auditors thereon.MoreLess
8 for0 against- To appoint Dr. Sanjay Sharma who retires by rotation as a Director and being eligible, offers himself for re-appointment.9 for0 against
- To ratify remuneration payable to M/s. Sachin Gupta & Co., Cost Accountants, Cost Auditor for the financial year 2026-27.8 for0 against
- To appoint SBR & Co. LLP, Practicing Company Secretaries, as Secretarial Auditors of the Company from the financial year 2025-26 to 2029-30.9 for0 against
- To amend and ratify the PARK – Employee Stock Option Scheme 2025 as per SEBI (Share Based Employee Benefit and Sweat Equity) Regulations, 2021.
Against Angel One Mutual Fund, Bandhan Mutual Fund, Groww Mutual Fund, Mirae Asset Mutual Fund, Motilal Oswal Mutual Fund
- Angel One Mutual FundExercise price and Exercise Period inadequately disclosed; Governance & Transparency Concern: Excessive benefit may be extended to an individual employee; No absolute cap on maximum number of options that can be granted per employee or maximum benefit per employee; Discretion provided to Nomination and Remuneration Committee to alter the material terms of scheme.
- Bandhan Mutual Fund, Groww Mutual Fund, Motilal Oswal Mutual FundNo concern/ issue in proposed ratification and amendment per se. Compliance Concern is on account of Non-compliance with SEBI (SBEB & SE) Regulations, 2021: Exercise price and Exercise Period inadequately disclosed; Governance & Transparency Concern: Excessive benefit may be extended to an individual employee; No absolute cap on maximum number of options that can be granted per employee or maximum benefit per employee; Discretion provided to NRC to alter the material terms of scheme.
- Mirae Asset Mutual FundIn line with the internal voting guidelines (Passive holding)
3 for5 against - To amend and ratify extension of “PARK – Employee Stock Option Scheme 2025” to the Employees of Subsidiary Companies and Group Companies of the Company.
Against Angel One Mutual Fund, Bandhan Mutual Fund, Groww Mutual Fund, Kotak Mahindra Mutual Fund, Mirae Asset Mutual Fund, Motilal Oswal Mutual Fund, Taurus Mutual Fund
- Angel One Mutual FundInterlinked with resolution #5. Governance & Transparency Concern: Excessive benefit may be extended to an individual employee; No cap on maximum number of options that can be granted per employee or maximum benefit per employee; Benefit proposed to be extended to Group companies including Associate Company(ies) without adequate justification & no provision for reimbursement of cost to be incurred by the Company.
- Bandhan Mutual Fund, Groww Mutual Fund, Motilal Oswal Mutual FundNo concern on extending ESOP scheme to subsidiary employees. Non-compliance with SEBI (SBEB & SE) Regulations, 2021: Interlinked with resolution #5. Governance & Transparency Concern: Excessive benefit may be extended to an individual employee; No cap on maximum number of options that can be granted per employee or maximum benefit per employee; Benefit proposed to be extended to Group companies including Associate Company(ies) without adequate justification & no provision for reimbursement of cost to be incurred by the Company.
- Kotak Mahindra Mutual FundThe company seeks approval to extend the benefits of the scheme to eligible employees of the existing and future group companies including subsidiaries and associate companies. We do not favour the extension of ESOP scheme to the associate company. Hence, we do not favour the resolution.
- Mirae Asset Mutual FundIn line with the internal voting guidelines (Passive holding)
- Taurus Mutual FundThe company seeks approval to extend the benefits of the scheme to eligible employees of the existing and future group companies including subsidiaries and associate companies. While we support the grant of stock options to unlisted subsidiaries, we do not support extension of ESOP schemes to group and associate companies, as they may have their own ESOP schemes currently or in the future. Further, our view on this resolution is linked to resolution #5. Hence, we do not support the resolution.
2 for7 against
3 proposals not matched to one resolution
- Item 1, as a fund house numbered it1 for0 against
- Item 3, as a fund house numbered it1 for0 against
- Item 5, as a fund house numbered it
Against Taurus Mutual Fund
- Taurus Mutual FundThe company seeks approval to amend the scheme by increasing total number of options reserved under the scheme from 3,844,000 options to 8,638,617 options. The dilution on exercise of all the options is ~2.0% on expanded capital base. The exercise price is at the discretion of NRC but shall neither be less than the face value of share nor more than the fair market value of the share on the date of grant. The minimum vesting period of an option is one year with the maximum vesting period of five years from the date of grant of options. The exercise period is maximum of seven years from the respective date of vesting of options. We do not favour ESOP schemes where the exercise price can be at a significant discount (greater than 20%) to market price for time-based vesting of stock options. Further, we raise concern that the exercise period as per the scheme can be up to seven years, which is long. Employees can continue holding options without converting them into shares - giving them the full upside potential of any stock appreciation while avoiding the downside risks that remain for other shareholders. Given that the exercise price could be at a substantial discount to the prevailing market price, we do not support this resolution.
0 for1 against
Mutual fund votes, meeting of 3 Sep 2026, 9 fund houses
- Amending certain objects of Initial Public Offer (“IPO”) proceeds9 for0 against
Each fund house counted once, from its own disclosure; the reasons are its own words.
Stakes in unlisted companies
Reported in the filing for the quarter to Sep 2026.
- Unlisted stake boughtV3 Healthcare Private LimitedSince 31 Jul 2026
80.00% bought in the quarter; holding 80.00%, from 0.00%
- Unlisted stake boughtPark Medicity Prayagraj LimitedSince 8 Sep 2026
100.00% bought in the quarter; holding 100.00%, from 0.00%
Investor complaints and compliance
Quarter by quarter.
Investor complaints received and resolved, the company's own count
- Received
- Resolved
Open at the quarter's end
- The board is made up as the listing rules require
- Yes
- The board has a regular chairperson
- Yes
- The company has a risk management committee
- Yes
- The chair is related to the managing director
- Yes
- The filing has a part on fines and penalties
- No
- The filing has a part on tax disputes
- No
- There was a cyber security incident in the quarter
- No
The company's own answers in its filing.
How money raised was used
Reported for the quarter to Jun 2026.
| Raised | Amount raised | For | Set aside | Spent | Spent elsewhere |
|---|---|---|---|---|---|
| Public IssuesDec 2025, checked by Crisil Rating Limited | 770.00 | Repayment/ prepayment, in full or in part, of outstanding borrowings availed by our Company and our Subsidiaries | 380.00 | 380.00 | No |
| Public IssuesDec 2025, checked by Crisil Rating Limited | 770.00 | Funding capital expenditure for development of new hospital by our Subsidiary Park Medicity (NCR) Private Limited | 60.50 | 19.52 | No |
| Public IssuesDec 2025, checked by Crisil Rating Limited | 770.00 | Funding capital expenditure for purchase of medical equipment by our Company and our Subsidiaries, Blue Heavens Healthcare Private Limited and Ratangiri Innovations Private Limited | 27.46 | 3.61 | No |
| Public IssuesDec 2025, checked by Crisil Rating Limited | 770.00 | Unidentified inorganic acquisitions and general corporate purposes | 245.32 | 245.32 | No |